Orudis (Ketoprofen)

Ketoprofen, the active ingredient in Orudis, is a non‑steroidal anti‑inflammatory drug presented as a 50 mg tablet for oral use. It is indicated for the relief of mild to moderate pain and inflammation in adults. GNH USA supplies Orudis as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Orudis as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Orudis contains ketoprofen, a non‑steroidal anti‑inflammatory drug that acts on the prostaglandin pathway.

- Rheumatoid arthritis: reduces joint swelling, pain and stiffness. - Osteoarthritis: alleviates chronic joint pain and improves mobility. - Acute musculoskeletal pain: provides short‑term relief of sprains, strains and back pain. - Dysmenorrhea: lessens menstrual‑related cramping and discomfort. - Post‑operative pain: helps control pain following minor surgical procedures.

Ketoprofen may cause a range of adverse reactions, most of which are dose‑dependent and reversible.

Common Side Effects: - Gastrointestinal discomfort: nausea, dyspepsia or heartburn. - Headache: mild to moderate intensity. - Dizziness: transient light‑headedness. - Skin rash: mild erythema or itching. - Elevated liver enzymes: mild, asymptomatic changes.

Serious or Rare Side Effects: - Gastrointestinal ulceration or bleeding. - Severe skin reactions such ");